"What" Series

What advancements have been made in the field of transdermal drug delivery?

28 December 2023
3 min read

Transdermal drug delivery is a method of delivering medication through the skin to achieve systemic effects. It has gained significant attention due to its advantages over traditional routes of administration such as oral and intravenous (IV) administration. Several advancements have been made in the field of transdermal drug delivery that address the limitations associated with traditional routes of administration. Some of these advancements include:

1.Nanotechnology: The use of nanotechnology in transdermal drug delivery has revolutionized the way drugs are formulated and delivered. Nanoparticles can be designed to penetrate the stratum corneum, the outermost layer of the skin, more effectively than larger particles. This allows for increased bioavailability and faster onset of action compared to traditional transdermal drug delivery methods.

2.Microneedles: Microneedle technology has emerged as an alternative to hypodermic needles for transdermal drug delivery. These tiny needles create microchannels in the skin, allowing drugs to be absorbed into the body without causing pain or bleeding. Microneedle patches can also be designed to target specific layers of the skin, enabling more precise drug delivery.

3.Combination Therapies: Combination therapies involve using multiple drugs simultaneously to treat a particular condition. This approach has been successful in treating conditions like migraine headaches and Parkinson's disease. Transdermal drug delivery systems have enabled researchers to develop combination therapies by incorporating multiple active pharmaceutical ingredients (APIs) into a single device.

4.Material Science: The development of new materials used in transdermal drug delivery devices has led to improved drug release kinetics, stability, and skin adhesion. For example, hydrogels and polymer-based materials have been developed to improve the permeation of drugs across the skin barrier.

5.3D Printing: 3D printing technology has allowed for the creation of personalized transdermal drug delivery devices tailored to individual patient needs. These devices can be designed to optimize drug release rates based on factors such as patient age, weight, and genetic makeup.

6.Wearable Devices: Wearable transdermal drug delivery devices have become increasingly popular due to their ease of use and convenience. These devices can be worn discreetly and provide continuous drug delivery over extended periods, improving compliance and reducing the risk of non-adherence to treatment regimens.

7.Hydrogel-based Systems:Hydrogels provide a reservoir for drug storage and release, offering a sustained and controlled delivery platform. Hydrogel systems improve drug stability, enhance skin adhesion, and provide a favorable environment for drug release, addressing limitations associated with traditional topical formulations.

8.Chemical Enhancers:Novel chemical enhancers, such as penetration enhancers and permeation enhancers, are being developed to improve drug permeability through the skin.These enhancers help overcome the skin's natural resistance to certain drugs and enhance the bioavailability of therapeutic agents.

In conclusion, advancements in transdermal drug delivery have significantly addressed limitations associated with traditional routes of administration, such as pain, bleeding, and variable drug absorption rates. These advancements have led to more effective, convenient, and personalized treatment options for patients.

Wave Life Sciences initiates Phase 2 FORWARD-53 trial, treating Duchenne Muscular Dystrophy patients with WVE-N531
Latest Hotspot
3 min read
Wave Life Sciences initiates Phase 2 FORWARD-53 trial, treating Duchenne Muscular Dystrophy patients with WVE-N531
28 December 2023
Wave Life Sciences has commenced the Phase 2 FORWARD-53 study, beginning treatment with WVE-N531 for individuals with Duchenne Muscular Dystrophy.
Read →
Progress in the Research and Development of Cannabinoid Receptor New Drugs
Hot Spotlight
12 min read
Progress in the Research and Development of Cannabinoid Receptor New Drugs
27 December 2023
Cannabinoids can be categorized into three types based on their origin: endocannabinoids, phytocannabinoids, and synthetic cannabinoids.
Read →
Deciphering VEGF Inhibitors and Keeping Up with Their Recent Developments
Deciphering VEGF Inhibitors and Keeping Up with Their Recent Developments
27 December 2023
VEGF inhibitors are drugs that block the activity of vascular endothelial growth factor, crucial in angiogenesis.
Read →
TQB2450: A Quick Look at Its R&D Progress and Clinical Results from the 2023 ESMO_ASIA
ESMO 2023
4 min read
TQB2450: A Quick Look at Its R&D Progress and Clinical Results from the 2023 ESMO_ASIA
27 December 2023
On 2 Dec 2023, the latest clinical trial about TQB2450 for the treatment for patients with hepatocellular carcinoma at high risk of recurrence was presented in 2023 ESMO_ASIA.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.